ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L04AX04 | G | Lenalidomide - 5mg | 10182 | 156619/1 | LENOMA | 5mg | 21 | Capsule, hard | Oral | Lebiran SARL | Nano Fanavaran Darouei Alvand Co (Nano Alvand) | Iran | 68,908,116 L.L | 10.71 | E1 | Nano Fanavaran Darouei Alvand Co (Nano Alvand) | Iran | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L04AX04 | B | Lenalidomide - 5mg | 6055 | 218105/09 | REVLIMID | 5mg | 21 | Capsule | Oral | Droguerie de l'Union | Celgene International SARL | Switzerland | 105,106,076 L.L | 2.44 | E2 | Celgene International SARL | Switzerland | 2/5/2024 | 0 |
L04AX04 | G | Lenalidomide - 5mg | 11052 | 155322/1 | LENALIDOMIDE NEAPOLIS | 5mg | 21 | Capsule | Oral | Medis Pharm Drugstore | Neapolis Pharma | Tunisia | 68,908,116 L.L | 10.71 | E1 | Neapolis Pharma | Tunisia | 2/5/2024 | 0 |
L04AX04 | G | Lenalidomide - 5mg | 10997 | 117921/1 | LENALIDOMIDE OHRE PHARMA | 5mg | 21 | Capsule | Oral | Karout pharmacy | Synthon Hispania SL | Spain | 31,106,370 L.L | 19.35 | D | Ohre Pharma | France | 2/5/2024 | 0 |
L04AX04 | G | Lenalidomide - 5mg | 11261 | 177420/1 | LENALIDOMIDE SPC | 5mg | 21 | Capsule, hard | Oral | Advanced Healthcare Services SAL | Pharmaline SAL Licensed by Sudair Pharma Company, KSA | Lebanon | 71,647,217 L.L | 10.71 | E1 | 2/5/2024 | 0 |